Cargando…

Tumor suppressors revival in CLL

Detalles Bibliográficos
Autores principales: Carrà, Giovanna, Taulli, Riccardo, Morotti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509451/
https://www.ncbi.nlm.nih.gov/pubmed/28657542
http://dx.doi.org/10.18632/aging.101258
_version_ 1783250021532041216
author Carrà, Giovanna
Taulli, Riccardo
Morotti, Alessandro
author_facet Carrà, Giovanna
Taulli, Riccardo
Morotti, Alessandro
author_sort Carrà, Giovanna
collection PubMed
description
format Online
Article
Text
id pubmed-5509451
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-55094512017-08-03 Tumor suppressors revival in CLL Carrà, Giovanna Taulli, Riccardo Morotti, Alessandro Aging (Albany NY) Editorial Impact Journals LLC 2017-06-26 /pmc/articles/PMC5509451/ /pubmed/28657542 http://dx.doi.org/10.18632/aging.101258 Text en Copyright: © 2017 Carrà et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial
Carrà, Giovanna
Taulli, Riccardo
Morotti, Alessandro
Tumor suppressors revival in CLL
title Tumor suppressors revival in CLL
title_full Tumor suppressors revival in CLL
title_fullStr Tumor suppressors revival in CLL
title_full_unstemmed Tumor suppressors revival in CLL
title_short Tumor suppressors revival in CLL
title_sort tumor suppressors revival in cll
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509451/
https://www.ncbi.nlm.nih.gov/pubmed/28657542
http://dx.doi.org/10.18632/aging.101258
work_keys_str_mv AT carragiovanna tumorsuppressorsrevivalincll
AT taulliriccardo tumorsuppressorsrevivalincll
AT morottialessandro tumorsuppressorsrevivalincll